Bienaime Jean Jacques
CIK 0001221590
Chief Executive OfficerDirector
Filings
51
Latest Jun 1, 2026
Issuers covered
5
Showing
50 of 51
Page 1
Track record
48 of 55 open-market trades scored (87% price coverage) - 7 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 48 | 71% | +3.2% | +3.4% | +22.6% | -10.3% |
| 90 days | 44 | 73% | +4.6% | +7.2% | +25.8% | -17.7% |
| 180 days | 44 | 68% | +8.3% | +10.4% | +97.8% | -30.9% |
| 365 days | 44 | 73% | +16.5% | +14.4% | +192.1% | -42.0% |
Issuers
Companies where Bienaime Jean Jacques has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 29 | May 21, 2024 |
| IMNM | Immunome Inc. | 10 | May 19, 2026 |
| INCY | Incyte Corp | 5 | May 28, 2026 |
| KROS | Keros Therapeutics, Inc. | 5 | May 19, 2026 |
| ASND | Ascendis Pharma A/S | 2 | Jun 1, 2026 |
All filings
51 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|